ADCT-901

· ADC Therapeutics S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADCT-901, covering 2025-05-22 to 2025-05-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 in Participants With Selected Advanced Solid Tumors [Phase 1]

See pricing